Fractionated Laser Resurfacing for Actinic Keratosis and Skin Cancer Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a laser treatment called Fractionated Laser Resurfacing (FLR) can prevent skin issues in older skin, such as actinic keratosis (rough, scaly patches from sun exposure) and other non-melanoma skin cancers. Researchers test the treatment on one forearm to assess both short-term and long-term effects. Individuals diagnosed with actinic keratosis within the last six months and who have fair skin might be suitable candidates. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new preventative treatments for skin conditions.
Do I need to stop taking my current medications for the trial?
Yes, you will need to stop using any topical or oral anti-inflammatory medications or steroids, as well as any photosensitizing medications.
What prior data suggests that fractionated laser resurfacing is safe for geriatric skin?
Research has shown that fractionated laser resurfacing (FLR) is generally well-tolerated. In past studies, patients experienced improvements in skin texture and a reduction in sun damage. This treatment uses tiny laser beams to target and refresh the skin.
Some individuals might experience minor side effects like redness or swelling, but these typically resolve quickly. FLR has also shown promise in treating early signs of skin issues such as actinic keratosis. Evidence suggests it is a safe option for refreshing the skin and may help reduce the risk of future skin cancer.12345Why are researchers excited about this trial?
Fractionated Laser Resurfacing is unique because it offers a novel approach to treating actinic keratosis and preventing skin cancer by using laser technology. Unlike traditional treatments like cryotherapy, topical medications, or chemical peels, which can be invasive, take time to heal, or might target the surface of the skin, this laser treatment works by precisely targeting and vaporizing damaged skin cells in a fractionated manner. This means it only treats small areas at a time, allowing for faster recovery and minimal downtime. Researchers are excited about this because it not only treats existing lesions effectively but also promotes healthier skin regeneration, potentially reducing the risk of future skin cancers.
What evidence suggests that fractionated laser resurfacing might be an effective treatment for actinic keratosis?
Research has shown that fractionated laser resurfacing (FLR) effectively treats sun-damaged skin and early-stage conditions like actinic keratosis. Studies have found that FLR improves skin texture and reduces skin cancer risk by removing damaged skin cells. Evidence suggests that this treatment provides protection lasting at least two years. In this trial, participants will receive FLR treatment on either the left or right forearm. The laser creates tiny wounds in the skin, prompting the body to heal and renew it. This process not only clears existing damage but may also help prevent future skin problems.12456
Who Is on the Research Team?
Jeffrey B Travers, MD, PhD
Principal Investigator
Wright State University
Are You a Good Fit for This Trial?
This trial is for people aged 60 or older with a recent diagnosis of Actinic Keratosis, fair skin (Fitzpatrick Type I or II), and both forearms intact. They must understand the study's procedures and risks/benefits, and be able to consent. Excluded are those allergic to lidocaine, on photosensitizing meds, pregnant/nursing women, users of anti-inflammatory drugs/steroids, uncontrolled diabetics, individuals prone to abnormal scarring or worsening of conditions in sunlight.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive fractionated laser resurfacing treatment on one forearm
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Fractionated Laser Resurfacing
Fractionated Laser Resurfacing is already approved in United States, European Union, Canada for the following indications:
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jeffrey B. Travers, MD, PhD
Lead Sponsor
Wright State University
Lead Sponsor